MedPath

Eye & ENT Hospital of Fudan University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

101

Active:3
Completed:17

Trial Phases

6 Phases

Early Phase 1:6
Phase 1:2
Phase 2:8
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (82 trials with phase data)• Click on a phase to view related trials

Not Applicable
56 (68.3%)
Phase 2
8 (9.8%)
Early Phase 1
6 (7.3%)
Phase 4
6 (7.3%)
Phase 3
4 (4.9%)
Phase 1
2 (2.4%)

Intracochlear Injection of Glucocorticoid

Not Applicable
Not yet recruiting
Conditions
Sudden Sensorineural Hearing Loss (SSNHL)
Interventions
Drug: intracochlear triamcinolone acetonide injection
Drug: intracochlear injection of dexamethasone through the round window membrane
Drug: intracochlear dexamethasone injection and intratympanic dexamethasone injection
Drug: intratympanic dexamethasone injection
First Posted Date
2025-08-21
Last Posted Date
2025-08-21
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
150
Registration Number
NCT07134075
Locations
🇨🇳

Fenyang Road 83, Shanghai, Shanghai, China

Efficacy and Safety of LLM-Based CBT for Tinnitus

Not Applicable
Recruiting
Conditions
Tinnitus
First Posted Date
2025-08-01
Last Posted Date
2025-08-12
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
93
Registration Number
NCT07097909
Locations
🇨🇳

Fudan University Eye Ear Nose and Throat Hospital, Otorhinolaryngology Department, Shanghai, Shanghai, China

Toric Intraocular Lens Implantation for Pediatric Aphakia

Not Applicable
Completed
Conditions
Pediatric Cataract
Congenital Cataract
First Posted Date
2025-07-28
Last Posted Date
2025-07-28
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
183
Registration Number
NCT07088796
Locations
🇨🇳

Eye and ENT hospital Fudan University, Shanghai, Shanghai, China

hAM for Inferior RRD

Not Applicable
Recruiting
Conditions
Rhegmatogenous Retinal Detachment
First Posted Date
2025-07-24
Last Posted Date
2025-07-28
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
50
Registration Number
NCT07081945
Locations
🇨🇳

EyeEntFudan, Shanghai, Shanghai, China

Effectiveness, Stability and Influence Factors of Femtosecond Laser Assisted Cataract Surgery

Recruiting
Conditions
Corneal Astigmatism
Cataract
First Posted Date
2025-07-23
Last Posted Date
2025-07-23
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
105
Registration Number
NCT07081919
Locations
🇨🇳

Eye and Ear, Nose, and Throat Hospital of Fudan University, Shanghai, Shanghai, China

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 20
  • Next

News

GenEditBio Doses First Patient in World's First In Vivo CRISPR Trial for TGFBI Corneal Dystrophy

GenEditBio has dosed the first patient in a groundbreaking investigator-initiated trial of GEB-101, marking the world's first clinical study of an in vivo CRISPR-Cas ribonucleoprotein-based genome editing therapy for TGFBI corneal dystrophy.

Bilateral Gene Therapy Restores Hearing in Both Ears for Children with Inherited Deafness

Five children with DFNB9 inherited deafness gained hearing in both ears after receiving bilateral gene therapy targeting OTOF gene mutations in a world-first clinical trial.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.